Следене
Elizabeth Lorenzi
Elizabeth Lorenzi
Berry Consultants
Потвърден имейл адрес: berryconsultants.net
Заглавие
Позовавания
Позовавания
Година
Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19
ATTACC, ACTIV-4a, and REMAP-CAP Investigators
New England Journal of Medicine 385 (9), 790-802, 2021
10432021
Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial
DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ...
Jama 324 (13), 1317-1329, 2020
8352020
Interleukin-6 receptor antagonists in critically ill patients with Covid-19
Remap-Cap Investigators
New England Journal of Medicine 384 (16), 1491-1502, 2021
6132021
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ...
JAMA 326 (6), 499-518, 2021
4772021
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ...
Jama 326 (17), 1690-1702, 2021
1932021
Development and validation of machine learning models to identify high-risk surgical patients using automatically curated electronic health record data (Pythia): A …
KM Corey, S Kashyap, E Lorenzi, SA Lagoo-Deenadayalan, K Heller, ...
PLoS medicine 15 (11), e1002701, 2018
1742018
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
YM Arabi, AC Gordon, LPG Derde, AD Nichol, S Murthy, F Al Beidh, ...
Intensive Care Medicine, 1-20, 2021
902021
Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: a randomized clinical trial.
CA Bradbury, PR Lawler, SJ Stanworth, BJ McVerry, Z McQuilten, ...
Jama, 1247-1259, 2022
892022
Long-Term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ...
JAMA 329 (1), 39-51, 2023
882023
WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of IL-6 antagonists and mortality among patients hospitalized for …
M Shankar-Hari, CL Vale, PJ Godolphin, D Fisher, JPT Higgins, F Spiga, ...
Jama 326 (6), 499-518, 2021
672021
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma
EC Lewis, JM Kraveka, W Ferguson, D Eslin, VI Brown, G Bergendahl, ...
International journal of cancer 147 (11), 3152-3159, 2020
462020
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19
EC Goligher, PR Lawler, TP Jensen, V Talisa, LR Berry, E Lorenzi, ...
JAMA, 2023
412023
Propensity Score Weighting for Causal Subgroup Analysis
S Yang, E Lorenzi, G Papadogeorgou, DM Wojdyla, F Li, LE Thomas
Statistics in Medicine; https://onlinelibrary.wiley.com/doi/10.1002/sim.9029, 2020
362020
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19: A Randomized …
S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, K Fareed, ...
JAMA 329 (14), 1183-1196, 2023
322023
Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis
PJ Godolphin, DJ Fisher, LR Berry, LPG Derde, JV Diaz, AC Gordon, ...
PloS one 17 (7), e0270668, 2022
192022
Eflornithine as postimmunotherapy maintenance in high-risk neuroblastoma: Externally controlled, propensity score–matched survival outcome comparisons
J Oesterheld, W Ferguson, JM Kraveka, G Bergendahl, T Clinch, ...
Journal of Clinical Oncology, JCO. 22.02875, 2023
112023
Simvastatin in critically ill patients with Covid-19
REMAP-CAP Investigators
New England Journal of Medicine 389 (25), 2341-2354, 2023
102023
Intravenous vitamin C for patients hospitalized with COVID-19: two harmonized randomized clinical trials
S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, K Fareed, ...
JAMA 330 (18), 1745-1759, 2023
102023
Choice of dose level for a randomized clinical trial of low-dose bevacizumab vs laser for type 1 retinopathy of prematurity
RT Kraker, DK Wallace, RW Beck, CT Saunders, E Lorenzi, BM Melia, Z Li, ...
JAMA ophthalmology 139 (10), 1143-1144, 2021
82021
Predictive Hierarchical Clustering: Learning clusters of CPT codes for improving surgical outcomes
EC Lorenzi, SL Brown, Z Sun, K Heller
Machine Learning for Healthcare Conference, 231-242, 2017
62017
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20